USANA Health Sciences Inc. - Form 8-K Summary
Business Context and Reporting Period
USANA Health Sciences, Inc. (USNA) filed this Current Report on Form 8-K on February 17, 2026. The filing announces the release of financial results for the fourth quarter and the full fiscal year ended January 3, 2026. The company is incorporated in Utah and trades on the New York Stock Exchange.
Key Financial Metrics
The provided text serves as a cover document referencing the press release and management commentary but does not contain specific numerical data. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics for the reported period.
Material Changes
Specific material changes versus the prior comparable period are not detailed in this 8-K text. The document indicates that detailed operational results and comparisons are contained within the attached exhibits (Exhibit 99.1 and 99.2).
Guidance, Outlook, and Management Commentary
- Management Commentary: The company announced the posting of a "Management Commentary" document on its corporate website.
- Conference Call: Executives scheduled a conference call with investors to discuss the results, featuring brief remarks followed by a question-and-answer session.
- Disclosure Status: The information is furnished under Regulation FD (Item 7.01) but is explicitly stated not to be "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other registration statements.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 and full-year 2026 revenue and earnings figures.
- Access Exhibit 99.2 (Management Commentary) for detailed margin analysis and operational updates.
- Verify the date and time of the investor conference call on the company website (www.usana.com).
- Confirm that the fiscal year end date is January 3, 2026, when comparing to prior periods.